The hypotheses presented so far are plausible. I'll chip in one more:
Atherosclerosis stems to a great extent from oxidation of the LDL apolipoprotein B100 by ROS in the bloodstream. Because there is
only one APOB100 per LDL particle, any modification to the APOB100 makes the LDL unable to bind LDL receptors and appears foreign to the immune system. These molecules are scavenged by macrophages (using scavenger receptor-A), and since SR-A is not down-regulated by cholesterol, these cells are able to accumulate large amounts of cholesterol (foam cells) before spilling it as they die.
Clearly, elevated LDL will result in competition at the LDL receptors of peripheral tissues and prolong the circulating time of LDL in the bloodstream, increasing the opportunity for APOB100 to become oxidized or otherwise modified, and increasing the opportunity for them to be scavenged by SR-A. Obviously, type IIA familial dyslipidemia inflates these statistics. Type I dyslipidemia, not subject to same limitations, does not. Furthermore, LDL contains 100-fold more cholesterol per particle than chylomicrons.
Edit: a quick review of literature does show, however, a positive relationship between chylomicron elevation and atherosclerosis, although "there have been as yet no clinical studies that have investigated the relationship between apo B48 and cardiovascular events."
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189596/